Atlas Trials

A Study to Evaluate SGB-3403 in Healthy Volunteers and Subjects With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)

Clinical trial NCT06239714 · UNKNOWN

Trial details

NCT number
NCT06239714
Sponsor
Suzhou Sanegene Bio Inc.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Hyperlipidemias
Start date
2024-02-18
Primary completion
2025-02-18
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.